Evaluation of Nasal Mucociliary Clearance in Recently Diagnosed Covid-19 Patients Before Treatment

Basit Öğe Kaydı
dc.authoridSungur, Mehmet Ali/0000-0001-5380-0819en_US
dc.authoridHabiloglu, Arif Dogan/0000-0001-8122-8768en_US
dc.authorwosidSungur, Mehmet Ali/K-9052-2015en_US
dc.contributor.authorKoder, Ahmet
dc.contributor.authorKilicaslan, Saffet
dc.contributor.authorBelada, Abdullah
dc.contributor.authorHabiloglu, Arif Dogan
dc.contributor.authorAtaoglu, Ozlem
dc.contributor.authorSungur, Mehmet Ali
dc.contributor.authorAtik, Dursun
dc.date.accessioned2024-08-23T16:03:50Z
dc.date.available2024-08-23T16:03:50Z
dc.date.issued2023en_US
dc.departmentDüzce Üniversitesien_US
dc.description.abstractObjective: Our study aims to evaluate the nasal mucociliary clearance (NMC) in Covid-19 patients who have been recently diagnosed and not been treated yet and investigate how Covid-19 affects NMC.Methods: A total of 120 participants, who applied to Duzce Ataturk State Hospital between September and November 2020, were included in our study. 60 of them were the participants, diagnosed with Covid-19. And 60 of them were the control group. The age range was 18 to 66. 60 participants, diagnosed with Covid-19 and not yet treated, were included in our study. Those with taste disorders were excluded from the study. The control group consisted of 60 healthy volunteers. NMC was evaluated using a saccharin test. The results were compared in the Statistical Package for Social Sciences (SPSS).Results: The study group, which consisted of 60 Covid-19 participants of whom treatment was not yet started, and the 60-participant healthy control group were evaluated in our study. The average age of the study group was 40,72 +/- 12,96 and 39,16 in the control group. The average NMC was 15,95 +/- 3,37 in the study group, and 8,38 +/- 1,03 in the control group. When evaluated statistically, it was found higher in the study group (p<0,001).Conclusions: NMC acts as a barrier for inhaled foreign bodies. It is a non-specific protection system against airborne pathogens. Consequently, NMC extends in Covid-19 patients.en_US
dc.identifier.doi10.18521/ktd.1217744
dc.identifier.endpage312en_US
dc.identifier.issn1309-3878
dc.identifier.issue3en_US
dc.identifier.startpage308en_US
dc.identifier.trdizinid1203065en_US
dc.identifier.urihttps://doi.org/10.18521/ktd.1217744
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1203065
dc.identifier.urihttps://hdl.handle.net/20.500.12684/13937
dc.identifier.volume15en_US
dc.identifier.wosWOS:001099802900005en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherDuzce Univ, Fac Medicineen_US
dc.relation.ispartofKonuralp Tıp Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19en_US
dc.subjectNasal Mucociliary Clearanceen_US
dc.subjectSmell Disordersen_US
dc.titleEvaluation of Nasal Mucociliary Clearance in Recently Diagnosed Covid-19 Patients Before Treatmenten_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu